Description
A prodrug form of the KCC2 activator CLP 257; increases the mechanical paw withdrawal threshold in a rat model of peripheral nerve injury and reverses morphine-induced hyperalgesia in rats at 100 mg/kg; restores stepping ability, as well as increases body weight support and stride length, in a mouse model of paralysis at 35 mg/kg
Formal name: 1-pyrrolidinecarboxylic acid, 5-fluoro-2-[(Z)-[4-oxo-2-(tetrahydro-1(2H)-pyridazinyl)-5(4H)-thiazolylidene]methyl]phenyl ester
Synonyms:
Molecular weight: 404.5
CAS: 1181083-81-7
Purity: ≥98%
Formulation: A crystalline solid